Jane Lauder | Founder, TAW Ventures
After nearly three decades at Estée Lauder Companies, Jane Lauder is applying prestige beauty’s standards of rigor, trust, and long-term brand equity to pet health through TAW Ventures. She shares how she evaluates founders, why pet longevity is still underestimated, and where she sees the biggest white space emerging over the next decade.
After nearly three decades helping build one of the most trusted portfolios in consumer brand history, Jane Lauder is now applying those same standards of rigor, trust, and long-term brand equity to the pet industry.
Through TAW Ventures, she's backing founders working at the intersection of science, longevity, and the human–animal bond — areas she believes are still underestimated despite the surge of capital into pet.
In this conversation, Jane shares how prestige beauty principles translate into pet health, what separates durable brands from short-term trends, and where she sees the biggest white space emerging over the next decade.
You spent nearly 30 years inside The Estée Lauder Companies. How did that experience prepare you for this new chapter in your professional career?
I grew up professionally at The Estée Lauder Companies, and those years shaped how I think as a leader. I learned how to build brands that become part of people's daily routines, which is incredibly personal. So much of that is about earning trust and creating an emotional connection. In prestige beauty, consumers are discerning and informed. They expect products to work, they expect transparency, and they expect proof behind every promise.
I've found that mindset translates directly to pet health and wellness. Today's pet parents are asking the same kinds of questions I saw emerge in beauty: What's in this? Does it work? Can I trust who is behind it? After nearly three decades where quality, efficacy, and consumer trust were non-negotiable, moving into pet felt less like a career pivot and more like an opportunity to apply those same principles to a category I'm deeply passionate about.
Other Interviews
More conversations with founders, operators, and investors building the future of pet care.
Alexandru Bacita | Co-Founder & COO, The Cat Health Company
Cats are living longer, but the drugs for age-related disease have not kept pace. The Cat Health Company, a clinical-stage biotech, has three drugs in trials and 11 more preclinical candidates, and has out-licensed its first therapeutic. Co-founder and COO Alexandru Bacita explains why cats compress the drug-development loop, how the company targets muscle loss and kidney disease first, and why the route to longevity runs through veterinarians and pharma partners.
Elias Weiss Friedman | Founder, The Dogist Company
Elias Weiss Friedman spent a decade turning street photography into The Dogist, one of the largest dog-focused audiences online. Now he's testing whether that trust extends to physical products, starting with Vitality, a vet-formulated antioxidant chew built with Dr. Angela Rollins. He talks about the discipline of brand extension, the operational learning curve of a first physical product, and what a decade of stopping strangers on the street taught him about people, not just dogs.
Sarah McLean | Co-Founder & CEO, Big Damn Dog Co.
A joint supplement label that stopped at 60 pounds sent Sarah McLean looking for a product that did not exist. Big Damn Dog Co. is the bootstrapped answer: giant-breed formulations, dosing built for 120-pound dogs, and a customer list the founders still call by phone. Six months after launch, its Gravy Blend already accounts for roughly 40% of joint supplement sales.